Nearly 2,000 drug manufacturing plants are overdue for FDA inspections after COVID delays, AP finds

Nearly 2,000 Pharmaceutical Plants Are Overdue for FDA Checks After COVID Delays

Federal regulators responsible for the safety of the U.S. drug supply are still struggling to get back to where they were in 2019, before the COVID-19 pandemic upended factory inspections in the U.S. and across the world, the Associated Press has found. An AP analysis of FDA data shows that agency staffers have not returned […]

Nearly 2,000 drug manufacturing plants are overdue for FDA inspections after Covid delays

An AP analysis of FDA data shows that agency staffers are still struggling to get back to where they were in 2019, before the Covid pandemic.

Nearly 2,000 drug plants are overdue for FDA checks after COVID delays, AP finds

U.S. health inspectors are still struggling to address a massive backlog of pharmaceutical...

Nearly 2,000 drug manufacturing plants are overdue for FDA inspections after COVID delays, AP finds

U.S. health inspectors are still struggling to address a massive backlog of pharmaceutical plants that went uninspected during disruptions caused by COVID-19.

5 Insights from a Report on the Significant Backlog of Uninspected Drug Factories

FDA Faces Challenges in Catching Up on Drug Facility Inspections WASHINGTON — As the COVID-19 pandemic began in early 2020, the Food and Drug Administration (FDA) withdrew many of its safety inspectors from the field, resulting in a significant backlog of pharmaceutical plant inspections both in the U.S. and overseas. Nearly five years later, the FDA’s effectiveness in addressing this backlog and ensuring the safety of drug manufacturing facilit…

5 Takeaways From AP's Report On The Big Backlog Of Uninspected Drug Factories

WASHINGTON — When COVID-19 swept the world in early 2020, the Food and Drug Administration decided withdrew most of its safety inspectors from the field, creating a huge backlog of uninspected pharmaceutical manufacturing plants in the US and abroad. Nearly five years later, The Associated Press sought to evaluate the FDA’s performance in Catching up on inspections from factories that produce drugs used by millions of Americans. The FDA maintain…